Literature DB >> 15671105

Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study.

Primus E Mullis1, Iain C A F Robinson, Souzan Salemi, Andrée Eblé, Amélie Besson, Jean-Marc Vuissoz, Johnny Deladoey, Dominique Simon, Paul Czernichow, Gerhard Binder.   

Abstract

Four distinct familial types of isolated GH deficiency have been described so far, of which type II is the autosomal dominant inherited form. It is mainly caused by mutations within the first 6 bp of intervening sequence 3. However, other splice site and missense mutations have been reported. Based on in vitro experiments and transgenic animal data, there is strong evidence that there is a wide variability in phenotype in terms of the severity of GH deficiency. Therefore, we studied a total of 57 subjects belonging to 19 families suffering from different splice site as well as missense mutations within the GH-1 gene. The subjects presenting with a splice site mutation within the first 2 bp of intervening sequence 3 (5'IVS +1/+2 bp) leading to a skipping of exon 3 were found to be more likely to present in the follow-up with other pituitary hormone deficiencies. In addition, although the patients with missense mutations have previously been reported to be less affected, a number of patients presenting with the P89L missense GH form, showed some pituitary hormone impairment. The development of multiple hormonal deficiencies is not age dependent, and there is a clear variability in onset, severity, and progression, even within the same families. The message of clinical importance from these studies is that the pituitary endocrine status of all such patients should continue to be monitored closely over the years because further hormonal deficiencies may evolve with time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671105     DOI: 10.1210/jc.2004-1280

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Pharmacologic correction of dominant-negative GH1 deficiency causing mutations.

Authors:  Justin S Poling; John A Phillips; Joy D Cogan; Rizwan Hamid
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

3.  Frequent development of combined pituitary hormone deficiency in patients initially diagnosed as isolated growth hormone deficiency: a long term follow-up of patients from a single center.

Authors:  Aline P Otto; Marcela M França; Fernanda A Correa; Everlayny F Costalonga; Claudia C Leite; Berenice B Mendonca; Ivo J P Arnhold; Luciani R S Carvalho; Alexander A L Jorge
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 4.  Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Indian J Pediatr       Date:  2011-12-03       Impact factor: 1.967

Review 5.  Pleiotropic effects of growth hormone signaling in aging.

Authors:  Andrzej Bartke
Journal:  Trends Endocrinol Metab       Date:  2011-08-17       Impact factor: 12.015

Review 6.  Genetic causes and treatment of isolated growth hormone deficiency-an update.

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

7.  A molecular basis for variation in clinical severity of isolated growth hormone deficiency type II.

Authors:  Rizwan Hamid; John A Phillips; Cindy Holladay; Joy D Cogan; Eric D Austin; Philippe F Backeljauw; Sharon H Travers; James G Patton
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

8.  Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference.

Authors:  Nikki Shariat; Robin C C Ryther; John A Phillips; Iain C A F Robinson; James G Patton
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

Review 9.  Isolated growth hormone deficiency.

Authors:  Libia M Hernández; Phillip D K Lee; Cecilia Camacho-Hübner
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 10.  The molecular basis of hypopituitarism.

Authors:  Christopher J Romero; Suzana Nesi-França; Sally Radovick
Journal:  Trends Endocrinol Metab       Date:  2009-10-23       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.